Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock of the
...Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Benchmark Investments, LLC ("Holder"), as registered owner of this Purchase
Warrant, to Tenon Medical, Warrant of Stran & Company, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], from May 12, 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], November 12, 2026 (the "Expiration Date"), but not thereafter, to subscribe
...for, purchase and receive, in whole or in part, up to [●] 10,101 shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] David W. Boral ("Holder"), as registered owner of this Purchase
Warrant, to Tenon Medical, Warrant of Stran & Company, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], from May 12, 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], November 12, 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchas
...e and receive, in whole or in part, up to [●] 62,287 shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Boustead Securities, LLC ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, MGO Global Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning
[●], 2022 January 18, 2023 (the
"Commencement "Issue Date"), and at or before 5:00 p.m., Eastern time,
[●], January 18, 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchase an
...d receive, in whole or in part, up to [●] 86,250 shares of common stock of the Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $6.25 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Digital Offering, LLC ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Inc., MDB Capital Holdings, LLC, a Delaware
corporation limited liability company (the "Company"), Holder is entitled, at any time or from time to time beginning
[●], 2022 [*], 2023 (the
"Commencement "Effective Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [*], 2028 (the "Expiration Date"), but not thereaf
...ter, to subscribe for, purchase and receive, in whole or in part, up to [●] [*] class A common shares of common stock of the Company, no par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $15 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] ARATANA THERAPEUTICS, INC. or its assigns ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Advaxis, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from March 19, 2014 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 March 19, 2024 (the "Expiration Date"), but not thereafter, to subscribe fo
...r, purchase and receive, in whole or in part, up to [●] 153,061 shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $4.90 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Viewtrade Securities, Inc. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, The Future Education Group Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [_] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [_] [DATE TH...AT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [_] shares of Class A common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[_] per Share; Share [110% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] A.G.P. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Odyssey Group International, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from August 6, 2020 (the
"Commencement "Effective Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 August 6, 2024 (the "Expiration Date"), but not thereafter, to subscribe
... for, purchase and receive, in whole or in part, up to [●] 220,000 shares (the "Shares") of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), "Common Stock"), subject to adjustment as provided in Section 6 hereof. The total Shares issuable pursuant to all Purchase Warrants is referred to herein as the "Warrant Shares." If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $0.01 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] U.S. Tiger Securities, Inc. ("Holder"), as registered owner of this Purchase
Warrant, to Tenon Medical, Warrant of Stran & Company, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], from May 12, 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], November 12, 2026 (the "Expiration Date"), but not thereafter, to subscribe
... for, purchase and receive, in whole or in part, up to [●] 14,964 shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] _______ ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Sigma Labs, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from September 29, 2020 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 April 2, 2025 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and recei
...ve, in whole or in part, up to [●] _______ shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $3.64 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Boustead Securities, LLC ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Cadrenal Therapeutics, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning
[●], 2022 January 19, 2023 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 January 19, 2028 (the "Expiration Date"), but not thereafter, to subscribe for, p
...urchase and receive, in whole or in part, up to [●] 84,000 shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $6.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
